Open access peer-reviewed chapter

Pregnancy in Myositis: Challenges and Pitfalls

By Codrina Mihaela Ancuta, Eugen Ancuta and Rodica Marieta Chirieac

Submitted: December 1st 2010Reviewed: April 26th 2011Published: September 15th 2011

DOI: 10.5772/23974

Downloaded: 3214

© 2011 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike-3.0 License, which permits use, distribution and reproduction for non-commercial purposes, provided the original is properly cited and derivative works building on this content are distributed under the same license.

How to cite and reference

Link to this chapter Copy to clipboard

Cite this chapter Copy to clipboard

Codrina Mihaela Ancuta, Eugen Ancuta and Rodica Marieta Chirieac (September 15th 2011). Pregnancy in Myositis: Challenges and Pitfalls, Idiopathic Inflammatory Myopathies - Recent Developments, Jan Tore Gran, IntechOpen, DOI: 10.5772/23974. Available from:

chapter statistics

3214total chapter downloads

More statistics for editors and authors

Login to your personal dashboard for more detailed statistics on your publications.

Access personal reporting

Related Content

This Book

Next chapter

Idiopathic Inflammatory Myopathies: A Review of Immunopathological Features and Current Models of Pathogenesis

By Cristina Cappelletti, Lucia Morandi, Marina Mora, Franco Salerno, Paolo Confalonieri, Renato Mantegazza and Pia Bernasconi

Related Book

First chapter

New Challenges for Old Diseases: The Impact of -Omics Technologies in the Understanding of Allergic Diseases

By Blanca Cárdaba, Miriam Aguerri, David Calzada and Carlos Lahoz

We are IntechOpen, the world's leading publisher of Open Access books. Built by scientists, for scientists. Our readership spans scientists, professors, researchers, librarians, and students, as well as business professionals. We share our knowledge and peer-reveiwed research papers with libraries, scientific and engineering societies, and also work with corporate R&D departments and government entities.

More About Us